Editorial

Karnataka’s decision to ban the sale and distribution of all tobacco and nicotine products, including gutka and pan masala, for one year is a decisive and welcome public health intervention. In a country where tobacco claims nearly 1.35 million lives annually and oral cancers remain disproportionately high, the state’s move recognises that incremental measures have proven insufficient. By targeting the entire spectrum of tobacco products rather than limiting the ban to gutka alone, the government has signalled seriousness about reducing consumption at the source.

The public health case is overwhelming. Smokeless tobacco products are deeply embedded in daily habits across social classes, particularly among the young and the economically vulnerable. They deliver high concentrations of nicotine and carcinogens, driving oral submucous fibrosis, cancers of the mouth and throat, and a heavy burden on already strained public hospitals. A time-bound, statewide prohibition creates space for behavioural change and sends a clear message that commercial interests cannot override population health.

Yet good intentions alone will not deliver results. Previous state-level gutka bans have repeatedly been undermined by weak enforcement, porous borders with neighbouring states, and the rapid emergence of black markets. Karnataka must avoid the same pitfalls. Sustained police and food-safety vigilance, strict penalties for violators, and coordination with neighbouring states are essential. Without these, the ban risks becoming another well-publicised announcement that quietly fails on the ground. The economic consequences also deserve attention. Thousands of small retailers and workers in the supply chain depend on these products for livelihood. A sudden ban without transitional support or skill-development alternatives can generate resentment and non-compliance. Equally, the government should expand access to cessation services, counselling, and affordable nicotine-replacement therapies so that dependent users are not left stranded.

Critics will invoke personal liberty and question whether the state should dictate private consumption choices. That argument carries weight in principle, but it weakens when the products in question impose massive external costs through disease, lost productivity, and public healthcare expenditure. Society has long accepted restrictions on substances that harm both users and those around them; tobacco fits that category.

Karnataka’s one-year ban is therefore both an opportunity and a test. If implemented rigorously, paired with education campaigns and cessation support, it can reduce disease burden and set a template for other states. If it becomes another poorly enforced decree, it will merely confirm the gap between policy ambition and administrative delivery. Public health cannot afford another such failure. The state must now match its resolve with relentless execution.

The report that an Air India pilot on the Phuket–Delhi sector tested positive for drugs, later attributed to sleep medication, is more than an isolated lapse. It is a serious breach of the fundamental principle that governs civil aviation: no one who is impaired, chemically or otherwise, may occupy the flight deck. Passenger lives depend on absolute clarity of mind and body. Anything less is unacceptable.

Aviation operates under a zero-tolerance regime for intoxicants and unauthorised substances. The Directorate General of Civil Aviation (DGCA) and international standards leave little room for ambiguity. Pilots are medically certified, routinely tested, and fully aware of the rules. Claiming that a positive result stemmed from sleep medication does not erase the violation. Whether the substance was prescribed, over-the-counter, or something else, the pilot’s decision to report for duty while potentially affected reveals a dangerous misjudgement. The law is clear; ignorance or personal convenience is no defence.

Yet the episode also points to a deeper, systemic problem. Fatigue is the silent threat in modern aviation. Tight turnarounds, long-haul sectors, circadian disruption, and aggressive rostering can leave crews chronically sleep-deprived. When rest is inadequate, some pilots turn to medication to force sleep or stay alert. That choice, however understandable in human terms, is incompatible with the responsibilities of the cockpit. The real question is not only why one pilot crossed the line, but whether the operating environment made that line easier to approach.

Airlines and regulators share accountability. Rosters must be designed with genuine recovery time, not merely regulatory minimums. Fatigue risk management systems need rigorous auditing, not paperwork compliance. Crews must feel able to declare unfitness without fear of career damage. Random testing must remain robust, and any positive result must trigger transparent investigation and decisive action. Public trust in air travel rests on the assumption that those at the controls are fully fit. A single compromised pilot undermines that trust for an entire system. Air India, the DGCA, and the wider industry must treat this incident as a wake-up call. Safety is non-negotiable. Neither personal excuses nor operational pressure can be allowed to dilute it.

• SAS Kirmani